Sentinel lymph node biopsy for breast cancer restaging

Read full text Summarise with VIRAT
Authors: Гулноз Голибовна Хакимова, I.V. Reshetov, A.D. Kaprin, Азиз Дилшодович Зикиряходжаев, Shakhnoz G. Khakimova, F. S. Khugaeva, V. O. Timoshkin, I.S. Duadze
Cited by: 0
References: 6

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Aim. To study the role of SLNB in patients with primary operable breast cancer (T1–2N0/N0–1) in restaging depending on the involvement of regional lymph flow (N status). Materials and methods. The retrospective study included 956 women with ductal/lobular stage I–IIB breast cancer. The median age was 54 [45; 63] years. According to the TNM clinical staging system, the patients predominantly had stage IA and IIA cancer. In 94 % of patients, no involvement of the SLN was detected. N+ status was registered in 6 % of patients. Histologically, breast cancer was predominantly represented by invasive ductal carcinoma in 87.5 % of the patients. Depending on the molecular subtype, luminal B HER2neu negative breast cancer was found in 38.2 % of the patients and luminal A subtype in 29.6 %. Moderately differentiated breast cancer was found in 63.5 % of the patients. Results. Median follow-up of the patients was 70.6 [60.0; 82.0] months. Depending on the involvement of the SLN, the following sentinel lymph node biopsy showed the following results: in 77.5 % of the patients, cN0 was confirmed histologically (pN0); in 2.7 %, SLN involvement was staged both clinically and pathologically (cN1–pN1); in 2.8 %, de-escalation of staging was detected (cN1–pN0); and in 0.6 %, SLNB revealed larger volume of damage to the regional lymph collector (cN1–pN2–3). 20 % of the patients underwent neoadjuvant chemotherapy (NACT). Among patients with cN1, SLN involvement (pN1) was significantly more often detected histologically in the group after NACT, 6.8 % versus 1.7 % (p = 0.0001), respectively. In 2.8 % with cN1–pN0, NACT efficacy was significantly higher (12.1 % versus 0.5 %, p = 0.00001). Also, in 16.3 % of the patients, pN1 was significantly more common in the group without NACT (18.5 % versus 7.4 %, p = 0.0002). Conclusion. Conducting SLNB restaged the involvement of the regional lymph collector of T1–2N0/N0–1 patients in 189 (19.8 %) cases. According to the results of SLNB, in 528 (55.2 %) patients with breast cancer, it was possible to refuse lymphadenectomy.

Fields of Study & Subjects

Breast Cancer Treatment Studies Breast Lesions and Carcinomas MRI in cancer diagnosis

Publication details

Journal / source
MD-Onco
Volume
6
Issue
1
Pages
24–28
Publication date
30 March 2026
Language
EN